Cleft palate is a common birth defect, but its etiopathogenesis is mostly unknown. Several studies have shown that cleft palate has a strong genetic component. Robin sequence consists of three of the following four findings: micrognathia, glossoptosis, obstructive apnea, and cleft palate. While cleft palate is mainly nonsyndromic, about 80 percent of Robin sequence cases are associated with syndromes. Mutations in genes coding for cartilage collagens II and XI, COL2A1, COL11A1 and COL11A2, have been shown to cause chondrodysplasias that are commonly associated with Robin sequence, micrognathia or cleft palate. We therefore analyzed a cohort of 24 patients with nonsyndromic Robin sequence, 17 with nonsyndromic cleft palate and 21 with nonsyndromic micrognathia for mutations in COL11A2. A total of 23 Robin sequence patients were also analyzed for mutations in COL2A1 and COL11A1. We detected two disease-associated mutations in patients with Robin sequence, an Arg to stop codon mutation in COL11A2 and a splicing mutation in COL11A1. Two putatively disease-associated sequence variations were found in COL11A1 in Robin sequence patients, one in COL11A2 in a patient with micrognathia and one in COL2A1 in two patients with Robin sequence. The results showed that sequence variations in these genes can play a role in the etiology of Robin sequence, cleft palate and micrognathia but are not common causes of these phenotypes.
Introduction
Oral clefts are among the most common birth defects, affecting approximately 1/500-1/2500 births depending on geographic origin, racial and ethnic backgrounds, and socioeconomic status. 1 While over 300 distinct syndromes associated with oral clefts have been identified, most clefts are considered nonsyndromic. 2 Robin sequence consists of three of the following four findings: micrognathia, glossoptosis, obstructive apnea and cleft palate. 3 The sequence is associated with numerous syndromes, including Stickler and velocardiofacial syndromes, while nonsyndromic forms comprise about 20% of all cases. 4 It has been suggested that a small mandible is the primary defect in nonsyndromic Robin sequence, causing the tongue to be placed posteriorly, which induces cleft palate and upper airway obstruction. However, it has been proposed recently that the cleft palate itself is the primary defect rather than micrognathia, implying that cleft palate and Robin sequence may share the same etiopathogenesis. 5 Nonsyndromic oral clefting has a complex etiology involving both genetic and environmental factors. 1, 2 Linkage and allelic association studies have yielded contradictory results, although they do indicate some role in clefting for endothelin 1, transforming growth factor a (TGFA), retinoic acid receptor a (RARA), MSX1 (HOX7), BCL3 and chromosome 6p. Evidence accumulated so far suggests that multiple genes, some of them acting with small effects, are involved in craniofacial development. 1, 2, [6] [7] [8] Collagen XI is a heterotrimer of a1(XI), a2(XI) and a3(XI) chains encoded by three distinct genes; COL11A1, COL11A2 and COL2A1. [9] [10] [11] The COL2A1 gene also codes for the a1 chain of collagen II, but the a3(XI) chain undergoes more extensive post-translational modification than the a1(II) chain. 12 Collagens II and XI are present throughout Meckel's cartilage, which provides mechanical support for the developing mandible. 13 Mutations in the genes coding for collagens XI (COL11A1 and COL11A2) and II (COL2A1) have been shown to cause chondrodysplasias that are commonly associated with micrognathia and palatal defects. 9, [14] [15] [16] [17] [18] Among the chondrodysplasias, Stickler syndrome, due to heterozygosity for mutations in COL2A1, is frequently associated with Robin sequence, but most patients with mutations in COL2A1 and COL11A1 also have associated eye phenotypes. Mutations in COL11A2 led to similar chondrodysplasia phenotypes, but patients lack the eye findings. This is because a1(II) and a1(XI) are found in the vitreous body of the eye but a2(XI) is replaced by the a2 chain of collagen V in this tissue. 18 For this reason, COL11A2 could be considered the best candidate for nonsyndromic cleft palate. We screened 24 patients with nonsyndromic Robin sequence, 17 with nonsyndromic cleft palate and 21 with nonsyndromic micrognathia for mutations in COL11A2. COL11A1 and COL2A1 were also analyzed in Robin sequence patients.
Materials and methods

Patients
Cleft patients in Finland have been treated centrally at the Red Cross Hospital for Plastic Surgery since 1948. The Cleft Center has been administered since 1985 by Helsinki University Central Hospital, where 103 patients with Robin sequence were treated during the years 1967-1996. The initial diagnosis was made at the referring hospital in each case. All these patients had cleft palate and a hypoplastic mandible, but breathing difficulties due to glossoptosis was not a consistent finding. We contacted 93 patients by letter. Of them, 33 were willing to participate, but 10 were excluded on account of a confirmed or suspected syndrome. Severe breathing difficulties immediately after birth had been confirmed in seven of the 23 unrelated Robin patients . None of the patients had eye findings, hearing deficit or skeletal abnormalities consistent with Stickler or Marshall syndrome. Seven of the patients reported that they had a relative who also had a cleft, but in only one case was the affected individual a first-degree relative.
One additional patient with nonsyndromic Robin sequence (62) was referred to us from the USA. The patient underwent a thorough clinical evaluation. An ophthalmological examination at the age of 5 years revealed no vitreous degeneration or detachment and indicated uncorrected 20/20 vision in the right eye and 20/25+ in the left. Hearing was within the normal limits in an audiological examination. There was no evidence of arthropathy, myalgia or loose-jointedness, skeletal radiographs were normal (not shown), and an echocardiogram was normal, with no evidence of mitral valve prolapse (not shown). At 5 years and 6 months of age the patient was in the 50th percentile for weight and height. The 38-year-old father was 175 cm tall, had a high-arched palate and a small, upturned nose, but no skeletal abnormalities or evidence of osteoarthritis (OA). An audiogram showed a hearing defect at high frequencies in the right ear, most likely attributable to a known history of acoustic trauma. The mother was 38 years old and had myopia, but no skeletal abnormalities or facial dysmorphia.
In all, 17 unrelated patients (1-17) with cleft palate were chosen from among 24 large multiplex families with nonsyndromic cleft palate on whom data had been collected for the Cleft Center of the Helsinki University Hospital over the years 1967-1996. A total of 250 patients had been contacted by letter, and the 24 largest pedigrees had been chosen for further examination. All the patients with nonsyndromic cleft palate had at least one affected relative who had nonsyndromic cleft palate. Patients with a confirmed or strongly suspected syndromic cleft palate were excluded.
In all, 17 patients with nonsyndromic micrognathia were recruited from patient populations at the Center for Craniofacial Disorders and Department of Dentistry at Montefiore Medical Center, Bronx, New York, and four from the maxillofacial surgery service at the University Hospitals of Cleveland (patients 41-61). The participants answered a health and family history questionnaire, and any who reported hearing loss, visual problems, joint problems or any other defects suggestive of a syndrome were excluded.
One lateral cephalometric radiograph was taken from each patient recruited in NY, and measurements of mandibular body (gonion-pogonion) and ramus length (articulare-gonion) on these cephalographs were compared with the Bolton standards 19 for evidence of micrognathia (defined as one or both of these measurements two standard deviations below Bolton's normal values). Blood samples were obtained from the patients and 150 unrelated Finnish individuals, who had no personal or family history of oral clefting. In addition, one Finnish patient with Marshall syndrome (MP) was included. Parental blood samples were available for patients 20, 22, 26, 33, 35, 39, 62, and MP.
Informed consent was obtained from all the participating subjects.
CSGE analysis and sequencing
Genomic DNA was used for mutation screening by conformation-sensitive gel electrophoresis (CSGE). 20 Even though CSGE may not detect all mutations, it has been estimated to have a sensitivity of over 90%. 20 The sequences corresponding to the 66 exons of COL11A2, and the 52 exons of COL2A1 11 and exon-flanking sequences were amplified by PCR to obtain products of 182-441 bp. The amplifications and CSGE analysis were performed as described earlier. 9, 16, 20 PCR products that showed new or obscure patterns on the CSGE gel were sequenced using an ABI Prism 377 automatic sequenator and the BigDye Terminator Cycle Sequencing Kit (Applied Biosystems).
Analysis of RNA Total RNA was isolated from Epstein-Barr virus-transformed lymphoblasts (patients 35 and MP). First-strand cDNA was synthesized with a Superscript Preamplification System (Gibco BRL) using poly-dT primer. PCR amplification of the cDNAs was performed using primers corresponding to exons flanking the sequence of interest, and nested primers were used for the second PCR amplification ( Table 1 ). The PCR amplifications were performed in a volume of 100 ml, using 2 ml of the cDNA/PCR product as a template, 34 pmol of each primer and 5 U of Ampli Taq Gold DNA polymerase. The PCR conditions included one cycle at 951C for 10 min and 33 cycles at 951C for 40 s, 601C for 40 s and 721C for 45 s, followed by one cycle at 721C for 10 min. The products were analyzed on agarose gels and by sequencing.
Results
CSGE analysis of COL2A1, COL11A1, and COL11A2 All 62 patient samples were analyzed for mutations in the COL11A2 gene, and the 23 patients with Robin sequence for mutations in the COL11A1 and COL2A1 genes as well.
Samples that had heteroduplexes on CSGE analysis were sequenced. The observed sequence variations were also searched for in 47 control samples by CSGE analysis, and the ones that were not found in the control set or appeared to be rare were looked for in all 150 control samples, again by CSGE. Six nucleotide substitutions were unique in that they were found only in patients and not in any of the 150 controls (Table 2) .
COL11A2 sequence variations A single-nucleotide mutation, C to T, was found in exon 4 of COL11A2 in patient 62, with Robin sequence (Table 2 ). This changed a codon CGA for Arg to a codon TGA for translation termination, and affected amino acid À310 from the first glycine of the major triple helix. Since the termination codon was in exon 4 of the 66 exon gene, it is likely that the mutant allele cannot produce any functional protein. DNA analysis of the parents indicated that the patient had inherited the mutation from her father. Even though the father did not have Robin sequence, he had a partial phenotype involving a higharched palate and a small, upturned nose which is typically associated with COL11A2 mutations. [14] [15] [16] [17] [18] A C to T change converting a codon CGG for Arg to a codon TGG for Trp was found in exon 13 in patient 53, with micrognathia. This affected amino acid À32 in the short N-terminal nontriple helical region between the minor and major triple helical domains. This substitution was interesting because Trp is not found in this region in any of the fibrillar collagens. In addition, Trp substitutions in the a2 and a3 chains of collagen IX have recently been found to be associated with lumbar disc disease. 21 Patient 53 is now in her 50s, 165 cm tall, with mild disc degeneration at L4 and early OA in one knee. She had The analysis also identified sequence changes that implied four other amino-acid substitutions, E-211K, L398P, P830T, and P1236L (data not shown). These are likely to be neutral, because their frequency was similar in the patients and controls.
COL11A1 sequence variations Analysis of exon 50 revealed an insertion of a T at the donor splice site of intron 50, in nucleotide position +3 in patient 26 with Robin sequence. This variation was not present in any of the 150 control samples, but it has been reported earlier in a patient with sporadic Marshall syndrome 9 ( Table 3 ). The present patient was of normal stature (186 cm) and had mild myopia (À1.5/À1.5D) but no hearing defect. All the other family members were unaffected. Neither of the parents had the mutation, and therefore, this patient also had a sporadic mutation. Even though RNA was not available to enable the consequence in terms of splicing to be examined, the mutation is predicted to result in a splicing defect.
9,22
The second unique sequence variation, IVS45+3G4A, was in COL11A1 in patient 22, with Robin sequence (Table  2 ). The mother was found to have the same sequence change. She had died of diabetic complications at the age of 28. Neither parent of patient 22 had cleft palate or any other craniofacial malformations, but the son of the proband's paternal aunt had cleft lip and palate. We had previously identified the same sequence variation in a patient with Marshall syndrome (MP) who had Robin sequence, severe myopia (À20/À20D), midfacial hypoplasia, hyperflexible finger joints, and a mild conductive hearing defect. The father of this latter patient was found to have the same mutation. He had no cleft palate but had a small mandible at birth. He also had mild myopia (À2.75/ À2.5D). The paternal grandmother had myopia (À6/À6D) and hyperflexible joints, but she did not have a cleft palate or hearing impairment. Both G and A nucleotides are commonly observed in position 3 of a donor splice site, but there are several examples of A to G mutations in this position causing aberrant splicing. 23 RT-PCR analysis failed to indicate a splicing defect (data not shown). To exclude the possibility of nonsense-mediated mRNA decay by means of a cryptic splice site, exon 5+9T4C polymorphism and exon 63+162C4T polymorphisms were analyzed. Sequencing showed that both polymorphisms were present in the mRNA, and thus both alleles were expressed. The analysis could not rule out the possibility of a quantitative splicing defect, however. One nucleotide substitution, IVS31+92T4A, was found in two patients with Robin sequence (20 and 33) but not in any of the 150 controls tested. Analysis of the parents' DNA revealed that both patients had inherited the substitution from one of their parents. Since the parents and other family members did not have any cleft defects, the substitution is not likely to be pathological, but we cannot rule out the possibility that it may predispose carriers to the phenotype.
The analysis also identified three amino-acid substitutions, L795P, P1007S, and P1008A, but these were not associated with clefting, as they were found equally frequently in the patient and control samples. COL2A1 sequence variations A unique nucleotide change was found in exon 17 of COL2A1 in two unrelated patients with Robin sequence (35 and 39), the last nucleotide C of this exon being replaced with T. This did not change the amino acid encoded. The father of patient 35 was heterozygous for the same change, but no one else in this family had cleft palate except the patient. The mother of patient 39 was found to be homozygous for the nucleotide change and had nonsyndromic cleft palate. She had three unaffected sisters and a brother. All four of her grandparents originated from the same region. Since RT-PCR analysis did not reveal any splicing defects and showed that both alleles were expressed, this mutation is not likely to be pathological, but it may be a predisposing, as three of the four individuals with this nucleotide variation had a clefting defect.
The analysis identified only one amino-acid substitution, V1131I, which is likely to be neutral, as it was found to be present equally frequently in the patients and controls.
Discussion
Mutations in the collagens II and XI genes cause syndromes that are often associated with cleft palate, Robin sequence and micrognathia, but it is possible that they may also cause nonsyndromic conditions. We identified here two disease-associated mutations in patients with Robin sequence, an R to X mutation in COL11A2 and a splicing mutation in COL11A1. Additionally, two putatively disease-predisposing mutations were found in COL11A1 in Robin sequence patients, one in COL11A2 in a patient with micrognathia and one in COL2A1 in two patients with Robin sequence.
It has been proposed that a major clefting locus may be contained in chromosome 6p, 2 and COL11A2 is located close, in head-to-tail orientation, to a gene for the retinoic acid receptor b, RXR-b, on 6p21.2. 10 The corresponding mouse genes have the same orientation and it has been demonstrated that some transcripts from Rxr-b extend into Col11a2. 24 Excess administration of retinoic acids to pregnant women is known to cause micrognathia and cleft palate, 25, 26 possibly by upregulating the expression of RXR-b, resulting in downregulation of COL11A2 and thereby producing a phenotype similar to those seen in connection with mutations in collagen XI genes. [14] [15] [16] [17] [18] This hypothesis is supported by a recent finding that loss of function mutations in COL11A2 cause otospondylomegaepiphyseal dysplasia (OSMED), a recessively inherited phenotype typically associated with Robin sequence. 16 Furthermore, one of the well-defined chromosomal regions for cleft susceptibility in the mouse is in or near the H2 locus, which is homologous to the human HLA locus on 6p and includes susceptibility for both corticosteroid-induced and vitamin A-enhanced cleft palate. 2 We identified here a stop codon mutation in COL11A2 in a patient with nonsyndromic Robin sequence. The father of the patient, who had the same mutation, had a high-arched palate and a small, upturned nose, but no cleft palate. Thus, the mutation caused nonsyndromic Robin sequence in the daughter, but was not fully penetrant in the father. Even though Robin sequence is associated with OSMED, which is typically caused by loss of function mutations in COL11A2, it is likely that COL11A2 haploinsufficiency can predispose to Robin sequence. This is supported by the previous findings that some carriers in OSMED families had a partial phenotype. 16 Furthermore, the role of COL11A2 in nonsyndromic conditions is supported by a recent finding that mutations in this gene can cause nonsyndromic hearing loss. 27 Another mutation, IVS50+3insT in COL11A1, was found in two patients, one with Robin sequence and the other with Marshall syndrome. 9 The finding that a mutation can result in two different but overlapping phenotypes is not surprising, and there are several examples of identical mutations in COL1A1 causing osteogenesis imperfecta that can vary from mild to lethal. 28 It is likely that a single genetic factor is not in itself enough to result in clefting, and that other, as yet unknown genetic or environmental factors modify the effects of mutations that predispose to clefting. It is thus possible that the unique sequence variations found here may be associated with the phenotypes but cannot alone induce clefting. This hypothesis is supported by the findings that nonsyndromic oral clefting is multifactorial and involves both genetic and environmental factors 1, 2 and that the concordance for nonsyndromic cleft palate in monozygotic twins is only 23.5%. 29 Even though disease-associated alterations in the three candidate genes were not found in the majority of patients, we can conclude that sequence variations in these genes may cause or predispose to nonsyndromic Robin sequence, cleft palate, and micrognathia in some cases.
